Old Web
English
Sign In
Acemap
>
authorDetail
>
Elisa DeStanchina
Elisa DeStanchina
Memorial Sloan Kettering Cancer Center
Molecular biology
Cancer
Biology
MAPK/ERK pathway
Mutant
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract B015: An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
2018
Molecular Cancer Therapeutics
Yaohua Xue
Luciano G. Martelotto
Timour Baslan
Alberto Vides
Martha Solomon
Kalyani Chadalavada
Elisa DeStanchina
Gouri Nanjangud
Michael F. Berger
Scott W. Lowe
Jorge S. Reis-Filho
Neal Rosen
Piro Lito
Show All
Source
Cite
Save
Citations (0)
DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy
2017
Molecular Cancer Research
Antonia A. Nemec
Laura Abriola
Jane S. Merkel
Elisa DeStanchina
Michelle DeVeaux
Daniel Zelterman
Peter M. Glazer
Joann B. Sweasy
Show All
Source
Cite
Save
Citations (12)
Abstract C174: RAF kinase dimerization mediates clinical acquired resistance to RAF/EGFR inhibition in BRAF V600E colorectal cancer
2015
Molecular Cancer Therapeutics
Rona Yaeger
Zhan Yao
David M. Hyman
Jaclyn F. Hechtman
Efsevia Vakiani
Andrea Cercek
José Baselga
Elisa DeStanchina
Leonard Saltz
Michael F. Berger
David B. Solit
Neal Rosen
Show All
Source
Cite
Save
Citations (0)
Prevention Of Minimal Residual Disease In Ph+ ALL
2013
Blood
Elisa DeStanchina
Gregory Carbonetti
Chong Chen
Scott W. Lowe
Charles J. Sherr
Show All
Source
Cite
Save
Citations (0)
1